Inhibrx Total Assets 2020-2021 | INBX

Inhibrx total assets from 2020 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Inhibrx Annual Total Assets
(Millions of US $)
2020 $144
2019 $26
Inhibrx Quarterly Total Assets
(Millions of US $)
2021-09-30 $129
2021-06-30 $142
2021-03-31 $125
2020-12-31 $144
2020-09-30 $144
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.195B $0.013B
Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.186B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69